INTRATHECAL NEUROLYSIS FOR PALLIATION OF LEGS SEVERE PAIN OF CERVICAL CANCER PATIENTS
DOI:
https://doi.org/10.54890/.v1i1.731Аннотация
Resume. The intrathecal neurolysis is a well-documented technique that can provide excellent and prolonged pain relief. In this study included twenty-five patients with cervical cancer, who suffered severe leg pain, resistant to opioids. Observation was enrolled during 8 weeks after intrathecal neurolysis. Patients were divided into 2 groups: group I included the patients who received intrathecal neurolysis, group II included patients who used morphine continuously. The pain score, performance status and morphine consumption were recorded regular at a week intervals. Pain scores were strongly reduced in group I after the intrathecal neurolysis (P≤0.05), and these patients used significantly less daily doses of morphine (P≤0.001). In group II pain score was stable, and patients continued to receive high doses of opioids with inadequate pain control and side effects of opioids. Physical performance improved within patients group I, in contrast, performance was decreased in group II (P≤0.001).
The intrathecal neurolysis is the effective method for palliation of severe intractable leg pain of patients with cervical cancer.
Ключові слова:
pain, intrathecal neurolysis, cervical cancer, morphine, opioids.Посилання
1. Comprehensive cervical cancer controls. A guide to essential practice. WHO 2014; 7.
2. Center for Health Development of Mongolia. Health indicators. Ulaanbaatar:2013; 87.
3. World Health Organization. World Cancer Report- International Agency for Research on Cancer. In: Stewart BW, Kleihues P, editors. Geneva, Switzerland: WHO, 2003;56.
4. Jaeckle KA, Young DF, Foley KM. The natural history of lumbosacral plexopathy in cancer. Neurology 1985;35:8-15.
5. Saphner T, Gallion HH, Van Nagell JR. Neurologic complications of cervical cancer. A review of 2261 cases. Cancer 1989;64:1147-51.
6. GayatriPalat, M. S. Biji, M. R. Rajagopa. Pain management in cancer cervix Indian J Palliative Care. 2005;11:2:65-66.
7. Grond S, Zech D, Schug SA, Lynch J, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 1991;6:411-22.
8. Smerdlow M. The role of chemical neurolysis. In advances in pain research and therapy. New York: Raven Press.1990;31:5
9. Lloyd JW. Subarachnoid and other clinical uses of phenol. In Racz GB ed, Techniques of neurolysis. Boston. Dordrecht, London: Kluwer Academic Publishers, 1989;33:56.
10. Wells JCD. The use of nerve of destruction for pain relief in cancer. A review. Palliative Medicine 1989;3:239.
11. Candido, K. & R.A. Stevens. 2003. Intrathecalneurolytic blocks for the relief of cancer pain. Best. Pract.Res. Clin. Anaesthe-siol.17:407–428.
12. Cousins, M., B. Dwyer & D. Bigg. Chronic pain and neurolytic blockade. 1988;2: 356-357.
13. Patt RB, Jain S. Resent advances in the management of oncologic pain. In: Stoelting RK ed. Advances in anesthesia. Chicago: Year book medical, 1989. p 355.
14. Paul J. Christo and Danesh Mazloomdoost. Interventional Pain Treatments for Cancer Pain. Ann. N.Y. Acad. Sci. 2008;1138:312.
15. Candido, K. and R.A. Stevens, Intrathecal neurolytic blocks for the relief of cancer pain. Best Pract Res Clin Anaesthesiol, 2003;17:407.
16. Wm. T. Peyton, e. J. Semansky, and a. B. Baker, Subarachnoid injection of alcohol for relief of Intractable pain with discussion of cord changes found at autopsy. 1937;709.
17. R. C. Hay. Subarachnoid alcohol block in the control of intractable Pain. Anesth. Analg 1962;41:12